The predicted increase would be driven by sustained high prices for raw materials, freight and shipping costs and the effects of tariffs on medical-surgical products manufactured in China, according to a news release from the healthcare performance improvement company.
Key items affected include gloves, needles, syringes and face masks. Enteral syringes will also see an impact from tariffs set to take effect in 2026, although Vizient said in the release that it helped delay the tariffs’ implementation, giving manufacturers time to diversify production outside of China.
In addition to med-surg products, other areas are expected to see cost increases, including construction, water services and medical gases.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
